Mike Kean and Billy Tamulynas discuss the key components of growth-ready technology for early-stage pharma companies and how to make optimal use of them.
Mike Kean and Billy Tamulynas
Advertisement
Mike Keanis a partner and Billy Tamulynas is a senior consultant on Sikich’s technology team.
Articles by Mike Kean and Billy Tamulynas
Advertisement
Latest Updated Articles
Lay the Tech Foundation for IPO SuccessPublished: October 18th 2019 | Updated:
Advertisement
Advertisement
Trending on PharmExec
1
FDA Appoints Tracy Beth Høeg as Acting Director of CDER
2
Pharmaceutical Executive Daily: FDA Names Tracy Beth Høeg as Acting Director of CDER
3
Beyond the Trial: How Integrating RWE and PROs is Redefining Treatment Success
4
FDA Approves Expanded Indication of Jaypirca for Adults with Relapsed or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
5
